Breakthrough Drug to Treat Multiple Sclerosis Wins FDA Approval
Studies found that Ocrevus was highly effective for patients with relapsing-remitting MS, reducing the number of episodes by half. The drug, however, costs $65,000 a year — pricey but still less expensive than current medications on the market.
Ways to deal with holiday stress, according to the experts04:52
Buddhist monk to Headspace co-founder: Andy Puddicombe's journey to mindfulness06:52
The Scott brothers try the 4-flight stair challenge02:30
19-year-old sings during brain surgery in incredible medical feat03:24
TODAY team tries sound therapy — take a listen04:20
Savannah, Hoda and Craig try the 4-flight stair challenge05:26